BGNE Jun 2024 160.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.0500

-1.4500

(-96.67%)

As of 09:37AM EDT. Market open.

Loading interactive chart...

Zacks
Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?
Argenx (ARGX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks
Travere (TVTX) Stock Jumps 5.2%: Will It Continue to Soar?
Travere (TVTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
GuruFocus.com
Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
The transaction was documented in an SEC Filing. Following this sale, the insider now owns 444,418 shares of BeiGene Ltd. BeiGene Ltd (NASDAQ:BGNE) is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer.